Congress Must Pass the ENACT Act
Advocates from all 50 states and the District are sharing their personal stories and urging members of Congress to address disparities in access to clinical trials. Will you join them?
Tell Congress to Address Disparities in Research and Care
Alzheimer’s research to date has not included sufficient numbers of Black, Hispanic, Asian or Native Americans to be representative of the U.S. population. The underrepresentation of these populations not only hinders the ability of researchers to understand these health disparities, it also restricts their knowledge of how an approved therapy or diagnostic may affect the populations most likely to need the treatment. And individuals from diverse communities continue to face significant barriers to accessing clinical trials, including substantial financial costs and extensive travel.
Are you a member of an underrepresented community? Have you or your loved ones experienced difficulty in accessing clinical trials? Are you concerned about equitable access to research, care and treatments?
Share your thoughts with your members of Congress and the Alzheimer's community in a brief video.
Join advocates like Alexis in asking your member of Congress to support the ENACT Act
Alexis G. strongly urges Rep. Raskin to support passage of the ENACT Act, which will alleviate many of the disparities that exist in Alzheimer's and dementia research.
Will you join her by asking YOUR member(s) of Congress to support this critical legislation?